a) Pfizer
b) Moderna
c) BioNtech
d) AstraZeneca
Moderna announced the results of its phase three trials on November 16, 2020 in which it reported that its COVID-19 vaccine candidate has proven to be 94.5% effective.
a) Pfizer
b) Moderna
c) BioNtech
d) AstraZeneca
Moderna announced the results of its phase three trials on November 16, 2020 in which it reported that its COVID-19 vaccine candidate has proven to be 94.5% effective.